C Peptide Level Fasting Test at Ayzal Lab

C Peptide Level (Fasting) at Ayzal Lab

The C-Peptide Level (Fasting) test is a highly specialized, evidence-based laboratory evaluation used to assess endogenous insulin production by the pancreas. Ayzal Lab, located in Lahore, Pakistan, offers this critical diagnostic service using advanced chemiluminescent immunoassay (CLIA) technology. C-peptide (connecting peptide) is a 31-amino-acid polypeptide that connects the alpha and beta chains of proinsulin. When the beta cells of the islets of Langerhans in the pancreas process proinsulin, it is cleaved into equal (equimolar) amounts of active insulin and inactive C-peptide before being released into the portal circulation. Because C-peptide has a longer half-life (approximately 20 to 30 minutes) than insulin (about 3 to 5 minutes) and is not significantly cleared by the liver, measuring its concentration provides a more stable, reliable, and accurate reflection of pancreatic beta-cell secretory capacity than measuring insulin levels directly.

This diagnostic test is of paramount clinical importance in differentiating between Type 1 and Type 2 diabetes mellitus, evaluating the cause of unexplained hypoglycemia, and monitoring pancreatic function after surgical resection or islet cell transplantation. At Ayzal Lab in Lahore, the fasting C-peptide test is performed under strict quality control protocols, ensuring that clinicians receive highly precise data to guide therapeutic decisions. By evaluating the secretory reserve of the endocrine pancreas, this test helps endocrinologists and internal medicine specialists distinguish between absolute insulin deficiency and insulin resistance, thereby optimizing patient management plans and preventing long-term diabetic complications.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the clinical accuracy of the fasting C-peptide level test, patients must adhere strictly to the following preparation guidelines:

• Fasting Requirement: The patient must fast for a minimum of 8 to 12 hours before sample collection. During this fasting period, only plain water is permitted. No other beverages, food, chewing gum, or candy should be consumed.
• Medication Review: Patients must inform their prescribing physician and the laboratory staff at Ayzal Lab of all medications, insulin therapies, oral hypoglycemic agents, vitamins, and supplements they are currently taking. Some medications may need to be temporarily held under medical supervision.
• Biotin Restriction: High doses of biotin (Vitamin B7) can interfere with immunoassay testing methods. Patients should avoid taking biotin supplements for at least 72 hours prior to the blood draw.
• Avoid Alcohol and Vigorous Exercise: Patients should refrain from consuming alcohol and engaging in strenuous physical activity for 24 hours before the test, as these factors can alter metabolic homeostasis and blood glucose dynamics.

During the Procedure

The collection of the blood specimen for the fasting C-peptide test at Ayzal Lab follows standardized clinical protocols to ensure patient safety and sample integrity:

• Patient Identification and Verification: The phlebotomist will verify the patient’s identity using at least two unique identifiers and confirm that the fasting requirement has been met.
• Venipuncture Site Selection: The patient is seated comfortably, and a suitable vein, typically the median cubital vein in the antecubital fossa of the arm, is selected.
• Aseptic Technique: The skin over the selected vein is thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) and allowed to air dry.
• Specimen Collection: A sterile, single-use needle is inserted into the vein, and blood is collected into a gold-top serum separator tube (SST) or a red-top clot activator tube.
• Post-Collection Care: Once the required volume of blood is obtained, the needle is gently withdrawn, and immediate manual pressure is applied to the puncture site with a sterile gauze pad to prevent hematoma formation. A small adhesive bandage is then applied.
• Sample Processing: The collected blood sample is allowed to clot completely at room temperature before being centrifuged to separate the serum. The serum is then analyzed using state-of-the-art automated analyzers at Ayzal Lab.

When is a C Peptide Level (Fasting) Test Performed?

Differentiating Type 1 from Type 2 Diabetes

Physicians frequently request a fasting C-peptide test when the classification of diabetes mellitus is ambiguous. In Type 1 diabetes, autoimmune destruction of pancreatic beta cells leads to an absolute deficiency of insulin, resulting in extremely low or undetectable fasting C-peptide levels. Conversely, in Type 2 diabetes, beta-cell function is initially preserved or hyperactive to compensate for peripheral insulin resistance, leading to normal or elevated fasting C-peptide levels. This differentiation is vital for determining whether a patient requires immediate, lifelong insulin therapy or can be managed with oral hypoglycemic agents and lifestyle modifications.

Investigation of Unexplained Hypoglycemia

Fasting C-peptide measurement is a cornerstone in the diagnostic workup of patients presenting with recurrent, unexplained hypoglycemia (low blood sugar). When blood glucose levels drop, endogenous insulin and C-peptide secretion should naturally suppress. If a patient has low blood glucose accompanied by high insulin and high C-peptide levels, it suggests endogenous overproduction, such as from an insulin-producing pancreatic tumor (insulinoma). If insulin is high but C-peptide is low, it indicates exogenous insulin administration (factitious hypoglycemia), as commercial insulin formulations do not contain C-peptide.

Monitoring Pancreatic Beta-Cell Function Over Time

For patients with established diabetes, the fasting C-peptide test is performed periodically to monitor the progressive decline of beta-cell function. In Type 2 diabetes, long-standing disease can lead to “beta-cell exhaustion,” where the pancreas gradually loses its ability to produce insulin. Measuring C-peptide levels helps endocrinologists determine when oral medications are no longer sufficient and when transition to basal-bolus insulin therapy is clinically indicated to maintain optimal glycemic control.

Evaluation of Pancreatic Surgery or Transplantation Outcomes

Patients who have undergone partial or total pancreatectomy, pancreatic islet cell transplantation, or whole-organ pancreas transplantation require close monitoring of their graft function. The fasting C-peptide test is used to assess the viability and secretory activity of the transplanted islet cells or remaining pancreatic tissue. A rising or stable C-peptide level indicates successful graft function and active insulin synthesis, while declining levels alert clinicians to potential graft rejection, failure, or tissue degradation.

Assessment of Insulin Resistance and Metabolic Syndrome

In patients presenting with clinical signs of metabolic syndrome, obesity, or polycystic ovary syndrome (PCOS), a fasting C-peptide test may be performed to evaluate the degree of insulin resistance. When peripheral tissues become resistant to insulin, the pancreas compensates by secreting larger amounts of proinsulin, leading to elevated fasting C-peptide levels in the blood. Identifying this state of hyperinsulinemia helps clinicians implement targeted therapeutic strategies, including insulin-sensitizing medications and dietary interventions, to prevent the onset of overt Type 2 diabetes.

What Does a C Peptide Level (Fasting) Detect?

The fasting C-peptide level test is highly sensitive and detects several physiological and pathological states related to glucose metabolism and pancreatic health, including:

• Absolute insulin deficiency (indicative of Type 1 Diabetes Mellitus)
• Endogenous insulin hypersecretion (hyperinsulinemia)
• Pancreatic beta-cell secretory reserve and functional capacity
• Presence of insulin-secreting neuroendocrine tumors (Insulinomas)
• Exogenous insulin administration or surreptitious insulin use
• Beta-cell exhaustion in long-standing Type 2 Diabetes
• Successful engraftment of pancreatic islet cell transplants
• Completeness of surgical removal of the pancreas (pancreatectomy)
• Peripheral insulin resistance associated with metabolic syndrome
• Subclinical pancreatic inflammation or chronic pancreatitis impact on endocrine function
• Factitious hypoglycemia versus organic hyperinsulinemic hypoglycemia
• Early-onset autoimmune diabetes in adults (LADA – Latent Autoimmune Diabetes in Adults)
• Gestational diabetes pancreatic response and postpartum recovery
• Efficacy of insulin-sensitizing therapeutic interventions
• Asymptomatic hypoglycemia etiology in pediatric populations

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The fasting C-peptide level test is processed using automated, high-throughput analyzers that ensure both rapid turnaround times and exceptional accuracy. Typically, the verified test report is available within 24 to 48 hours of sample collection. Patients and referring physicians in Lahore can access reports online through the secure Ayzal Lab digital portal, receive them via WhatsApp, or collect printed copies directly from the laboratory reception.

C Peptide Level (Fasting) Findings Overview

The table below outlines the clinical parameters evaluated during a fasting C-peptide test, along with typical normal ranges and potential abnormal findings with their clinical implications.

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Fasting Serum C-Peptide Concentration	0.78 to 1.89 ng/mL (Reference ranges may vary slightly by laboratory methodology)	Decreased (<0.5 ng/mL): Type 1 diabetes, beta-cell exhaustion in advanced Type 2 diabetes, pancreatectomy, or fasting state with normal insulin sensitivity. Increased (>2.0 ng/mL): Insulinoma, Type 2 diabetes (insulin resistance), renal insufficiency, Cushing’s syndrome, or sulfonylurea administration.
Fasting Plasma Glucose (Correlative)	70 to 99 mg/dL	Hypoglycemia (<70 mg/dL): Evaluated alongside C-peptide to diagnose insulinoma or factitious insulin use. Hyperglycemia (≥100 mg/dL): Evaluated to assess pancreatic response to elevated glucose.
C-Peptide to Insulin Ratio	Typically >1.0 (due to longer half-life of C-peptide)	Altered Ratio: Can indicate hepatic disease (reduced insulin clearance) or exogenous insulin administration (where insulin is high but C-peptide is disproportionately low).
Renal Clearance Function (Creatinine)	Normal renal function parameters	Elevated C-Peptide due to Renal Delay: Because C-peptide is excreted by the kidneys, renal impairment can falsely elevate serum C-peptide levels.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for C Peptide Level (Fasting)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, technologists, and phlebotomists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Ayzal Lab utilizes stringent internal and external quality control measures to ensure highly accurate and reproducible test results.
• Professional Reporting: Our diagnostic reports are detailed, clear, and structured to provide maximum clinical utility to your referring physician.
• Modern Diagnostic Approach: We employ advanced chemiluminescent immunoassay technology to deliver precise hormone and peptide measurements.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and stress-free environment for all patients.
• Convenient Location: Easily accessible facilities across Lahore make it simple for patients to undergo diagnostic testing without long commutes.
• Commitment to Accurate Diagnosis: We are dedicated to supporting your healthcare journey by providing timely, reliable, and evidence-based diagnostic insights.